Left Atrial Appendage Closure Device Market Report: Global Size, Trends, Competitive Analysis, Types, Applications And Outlook

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033

The Business Research Company offers in-depth market insights through Left Atrial Appendage Closure Device Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The left atrial appendage closure device market size has grown exponentially in recent years. It will grow from $1.39 billion in 2023 to $1.67 billion in 2024 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to prevalence of atrial fibrillation, stroke prevention strategies, clinical evidence and research, minimally invasive alternatives, patient preference for non-pharmacological options, aging population, physician training and expertise..

The left atrial appendage closure device market size is expected to see rapid growth in the next few years. It will grow to $3.21 billion in 2028 at a compound annual growth rate (CAGR) of 17.7%. The growth in the forecast period can be attributed to rising global burden of atrial fibrillation, focus on stroke prevention in high-risk patients, expanding patient awareness, integration into standard clinical practice, global efforts in cardiovascular disease management.. Major trends in the forecast period include emergence of percutaneous closure techniques, advancements in device designs, increasing use of imaging technologies, focus on minimally invasive approaches, tailored device selection for patient anatomy..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=13474&type=smp

Market Segmentation:
The left atrial appendage closure device market covered in this report is segmented -
1) By Product: Epicardial Left Atrial Appendage (LAA) Devices, Endocardial Left Atrial Appendage (LAA) Devices
2) By Procedure: Percutaneous, Surgical
3) By End-User: Hospital, Ambulatory Surgical Centers, Other End-Users

Major Driver - Elevated Prevalence Of Atrial Fibrillation Fuels Growth In The Left Atrial Appendage (LAA) Closure Device Market
The rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market going forward. Atrial fibrillation is a medical condition characterized by an irregular and often rapid heartbeat. It occurs when the heart's upper chambers, called the atria, do not beat in a coordinated and rhythmic manner. Left atrial appendage (LAA) closure devices are primarily used in treating atrial fibrillation by reducing the risk of stroke in patients with this cardiac arrhythmia and preventing blood clots from forming or escaping. For instance, in October 2022, according to reports published by the Centers for Disease Control and Prevention, a US-based government agency, atrial fibrillation was the predominant diagnosis in more than 454,000 hospital admissions each year in the US, and it is expected that 12.1 million people in the US will have atrial fibrillation in 2030. Therefore, the rising prevalence of atrial fibrillation is expected to propel the growth of the left atrial appendage (LAA) closure device market.

Competitive Landscape:
Major companies operating in the left atrial appendage closure device market report are Johnson And Johnson Pvt Ltd., Abbott Laboratories , Medtronic plc., Atrium Medical Corporation, Boston Scientific Corporation, Gore Medical Inc., Lepu Medical Technology Co. Ltd., MicroPort Scientific Corporation, AtriCure Inc., Dune Medical Devices Ltd., Lifetech Scientific Corporation, Sahajanand Medical Technologies Limited , Occlutech, Cardiva Medical Inc., Sentreheart Inc., Aegis Medical Group, EndoStim Inc., Conformal Medical Inc., Cardia Inc., Medical Device Business Service Inc., Protaryx Medical, Append Medical Ltd, Vascular Innovations Co. Ltd., Vivasure Medical Inc., Atritech Inc., CardiaMed AB, Cardialen Inc., Kalila Medical Inc.

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/left-atrial-appendage-closure-device-global-market-report

Top Trend - Breakthrough Innovation In Left Atrial Appendage Closure Devices
Major companies operating in the left atrial appendage closure device market are developing innovative products such as Watchman FLX to advance the treatment of non-valvular atrial fibrillation (NVAF) and help patients with an alternative to oral anticoagulation therapy. The Watchman FLX pro device is a self-expandable device implanted in the LAA to block the opening and prevent blood clots from forming. For instance, in September 2022, Boston Scientific Corporation, a US-based manufacturing company, received approval for Watchman FLX from the Food and Drug Administration, a US-based federal agency, to lower the chance of stroke in those with non-valvular atrial fibrillation (NVAF). It is designed to be more flexible and accessible to implant than previous versions of the Watchman device, making it a more viable option for a broader range of patients. Moreover, it is a safe and effective way to reduce the risk of stroke in people with NVAF, and it is a valuable option for patients who are not eligible for oral anticoagulation therapy or who have difficulty managing their oral anticoagulation therapy.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Left Atrial Appendage Closure Device Market Characteristics
3. Left Atrial Appendage Closure Device Market Trends And Strategies
4. Left Atrial Appendage Closure Device Market - Macro Economic Scenario
5. Left Atrial Appendage Closure Device Market Size And Growth
…..
27. Left Atrial Appendage Closure Device Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.